comprehensive -WSS

comprehensive

author：fashion 2025-09-30 05:49:56 - browse：724

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Congress may force more Covid

WSS

H5N1 bird flu virus started spreading in cows in Texas in December

Cue Health's Covid

In 'major milestone,' FDA approves first cell therapy for solid tumors

New study raises questions about niacin and heart health

FDA warns medical device makers about rise in fabricated data

Close Medicare's dangerous gaps in addiction treatment coverage

entertainment

comprehensive

explore

BioMarin wins approval for gene therapy to treat hemophilia A

New study raises questions about niacin and heart health

Tori Bowie and the unacceptable rates of Black maternal death

UnitedHealth financials solid despite Change Healthcare cyberattack

Apple is now the first public company to be valued at $3 trillion

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Measles policy set amid Florida outbreak alarms vaccine proponents

Dobbs anniversary: the lost opportunity of abortion as health care

Orangutan used medicinal plant to treat wound, first time ever seen

explore

Key Senate committee drafts bipartisan bill to stem drug shortages

Q&A: Jennifer Adair on making gene therapy available globally

Measles policy set amid Florida outbreak alarms vaccine proponents

Researchers tackle phage therapy hurdles for wider adoption

Dogs on Prozac: What pet anti

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

leisure time

entertainment

focus

knowledge